Functional cross-talk between aldosterone and angiotensin-(1-7) in ventricular myocytes

Hypertension

Volumn 61, Issue 2, 2013, Pages 425-430

  De Almeida, Pedro W MacHado ^a   De Freitas Lima, Ricardo ^a   De Morais Gomes, Enéas Ricardo ^a   Resende, Cibele Rocha ^a   Roman Campos, Danilo ^a   Gondim, Antonio Nei S ^a,e   Gavioli, Mariana ^a   Lara, Aline ^a   Parreira, Amanda ^a   De Azevedo Nunes, Sasha Luísa ^a   Alves, Márcia N M ^a   Santos, Sandra Lauton ^b,c   Alenina, Natalia ^d   Bader, Michael ^d   Resende, Rodrigo Ribeiro ^a   Dos Santos Cruz, Jader ^a   Souza Dos Santos, Robson Augusto ^a,e   Guatimosim, Silvia ^a,e  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^c Helena Antipoff Foundation   (Brazil)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e UNIVERSIDADE DO ESTADO DA BAHIA   (Brazil)

Author keywords

angiotensin; calcium; electrophysiology; myocytes

Indexed keywords

ALDOSTERONE; ANGIOTENSIN[1-7]; CYCLIC AMP DEPENDENT PROTEIN KINASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART VENTRICLE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

ALDOSTERONE; ANGIOTENSIN I; ANIMALS; CALCIUM; CALCIUM SIGNALING; CYCLIC AMP-DEPENDENT PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, CARDIAC; NITRIC OXIDE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84873059396     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.199539     Document Type: Article

References (27)

1. Park JB, Schiffrin EL. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. Am J Hypertens. 2002;15(2 Pt 1):164-169. (Pubitemid 34161092)
2. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990;82:1730-1736. (Pubitemid 20367976)
3. Brown NJ. Eplerenone: cardiovascular protection. Circulation. 2003;107: 2512-2518. (Pubitemid 36605237)
4. Struthers AD. The clinical implications of aldosterone escape in congestive heart failure. Eur J Heart Fail. 2004;6:539-545. (Pubitemid 39070505)
5. Delcayre C, Silvestre JS, Garnier A, Oubenaissa A, Cailmail S, Tatara E, Swynghedauw B, Robert V. Cardiac aldosterone production and ventricular remodeling. Kidney Int. 2000;57:1346-1351. (Pubitemid 30207889)
6. Sheppard KE. Corticosteroid receptors, 11 beta-hydroxysteroid dehydrogenase, and the heart. Vitam Horm. 2003;66:77-112. (Pubitemid 137640815)
7. Bénitah JP, Vassort G. Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes. Circ Res. 1999;85:1139-1145. (Pubitemid 30430618)
8. Wenzel S, Tastan I, Abdallah Y, Schreckenberg R, Schlüter KD. Aldosterone improves contractile function of adult rat ventricular cardiomyocytes in a non-acute way: potential relationship to the calcium paradox of aldosteronism. Basic Res Cardiol. 2010;105:247-256.
9. Gòmez AM, Rueda A, Sainte-Marie Y, et al. Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins. Circulation. 2009;119:2179-2187.
10. Grobe JL, Mecca AP, Mao H, Katovich MJ. Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol. 2006;290:H2417-H2423. (Pubitemid 43846070)
11. Santiago NM, Guimarães PS, Sirvente RA, Oliveira LA, Irigoyen MC, Santos RA, Campagnole-Santos MJ. Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling. Hypertension. 2010;55:889-896.
12. Guatimosim S, Dilly K, Santana LF, Saleet Jafri M, Sobie EA, Lederer WJ. Local Ca(2+) signaling and EC coupling in heart: Ca(2+) sparks and the regulation of the [Ca(2+)](i) transient. J Mol Cell Cardiol. 2002;34:941-950. (Pubitemid 35316142)
13. Rossier MF, Python M, Maturana AD. Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes. Endocrinology. 2010;151:2777-2787.
14. Rossier MF, Lenglet S, Vetterli L, Python M, Maturana A. Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes. Hypertension. 2008;52:721-728.
15. Dias-Peixoto MF, Santos RA, Gomes ER, Alves MN, Almeida PW, Greco L, Rosa M, Fauler B, Bader M, Alenina N, Guatimosim S. Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes. Hypertension. 2008;52:542-548.
16. Christ M, Günther A, Heck M, Schmidt BM, Falkenstein E, Wehling M. Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells. Circulation. 1999;99:1485-1491. (Pubitemid 29140916)
17. Ziolo MT, Katoh H, Bers DM. Positive and negative effects of nitric oxide on Ca(2+) sparks: influence of beta-adrenergic stimulation. Am J Physiol Heart Circ Physiol. 2001;281:H2295-H2303.
18. Gomes ER, Lara AA, Almeida PW, Guimarães D, Resende RR, Campagnole- Santos MJ, Bader M, Santos RA, Guatimosim S. Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway. Hypertension. 2010;55:153-160.
19. Güder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Störk S. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation. 2007;115:1754-1761. (Pubitemid 46648612)
20. Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol. 2005;289:H1560-H1566. (Pubitemid 41368998)
21. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich MJ. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol. 2007;292:H736-H742.
22. Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F, van Gilst WH. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation. 2002;105:1548-1550. (Pubitemid 34297630)
23. Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, Santos RA, Walther T, Touyz RM, Reudelhuber TL. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res. 2008;103:1319-1326.
24. Santos RA, Ferreira AJ, Nadu AP, Braga AN, de Almeida AP, Campagnole- Santos MJ, Baltatu O, Iliescu R, Reudelhuber TL, Bader M. Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats. Physiol Genomics. 2004;17:292-299. (Pubitemid 38924174)
25. Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol. 1996;108:277-293. (Pubitemid 26332539)
26. Zahradníková A, Minarovic I, Venema RC, Mészáros LG. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium. 1997;22:447-454.
27. Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol. 2005;67:69-98. (Pubitemid 40404486)